Prevalence and Seroprevalence of High-Risk Human Papillomavirus Infection

Abstract

OBJECTIVE: To estimate the prevalence and seroprevalence of high-risk human papillomavirus (HPV) in Korean girls and women. METHODS: We estimated the seroprevalence of HPV subtypes 16 and 18 among 1,094 girls and women aged 9–59 years and the prevalence of genital high-risk HPV among 902 women aged 20–59 years who visited our institution for a medical checkup. Genital high-risk HPV DNA was measured using liquid hybridization and polymerase chain reaction assays. Serum antibodies to HPV subtypes 16 and 18 were measured using a multiplexed competitive luminex technique. RESULTS: The prevalence of genital high-risk HPV was 12.6% among Korean women aged 20–59 years. It reached a peak of 23.2% at 20–29 years of age, decreasing thereafter but increasing again to 12.4% at 50–59 years of age. Human papillomavirus 56 was the most common subtype followed by HPV 18, HPV 52, and HPV 16. The seroprevalence of HPV subtypes 16 and 18 was 8.7% among Korean girls and women aged 9–59 years. It reached its highest peak of 13.4% at 25–29 years of age and decreased thereafter. It then reached a second peak of 10.9% at 40–49 years of age and plateaued thereafter. The seroprevalences of HPV subtypes 16 and 18 were 7.4% and 2.7%, respectively. In multivariable analysis, the prevalence and seroprevalence of high-risk HPV were correlated only with the number of lifetime sexual partners. CONCLUSION: High-risk HPV infection is common among Korean women. Our epidemiological data on high-risk HPV infection will help to assess vaccine policy and to establish a baseline for estimating vaccine efficacy. (Obstet Gynecol 2010;116:932–40)